Statement of retraction: Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial*
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | The Journal of Maternal-Fetal & Neonatal Medicine |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14767058.2025.2509344 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling the economic and health impact of substandard uterotonics in Senegal
by: Yi-Fang Ashley Lee, et al.
Published: (2025-04-01) -
Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
by: Fiona C Denison, et al.
Published: (2019-12-01) -
Elemental composition of placental cotyledons in cows with retained placenta
by: Safonov V.A., et al.
Published: (2024-12-01) -
Prevalence of retained placenta and its correlation with maternal demographic characteristics
by: Khansaa Hikmat Abdulrahman, et al.
Published: (2023-06-01) -
WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one?
by: Joshua P Vogel, et al.
Published: (2019-03-01)